Established in 1997, CNF is the CEI affiliate that actively invests in venture capital and private equity. CNF partners Robert Flanagan and Joe Del Guercio manage over $170 million in capital with current investments in life sciences, oil and gas, technology, telecommunications, and alternative energy.
CNF focuses on early and growth stage companies but will consider investments in later stages and selective public investments as well. CNF looks to partner with other venture capital and private equity firms and is an active investor providing strategic advice to its management teams.
CNF conducts thorough and efficient diligence processes but focuses most of its analysis on the potential investment’s management team and other key players. CNF believes that success is based on the right combination of people, experience, hard work, focus, and execution.
|TerraGo Technologies||3/13||Series B||$5.5M||3|
|Revance Therapeutics||6/11||Venture Round||$45M||7|
|Svelte Medical Systems||11/09||Debt||$6M||2|
|TerraGo Technologies||4/09||Venture Round||$3.44M||3|
|Overture Technologies||12/08||Series C||$6M||3|
|Innovative Biosensors||5/08||Venture Round||$9.5M||4|
|Digital Bridge Communications Corp.||1/08||Series B||$20M||4|
|Verax Biomedical||12/07||Series E||$2.54M||3|
|TerraGo Technologies||5/07||Series A||$6.3M||3|
|Vital Sensors||12/05||Venture Round||$1M||4|